Posterior reversible encephalopathy syndrome in an adult patient with acute lymphoblastic leukemia after remission induction chemotherapy

International Journal of Hematology

Volumn 95, Issue 2, 2012, Pages 204-208

  Tsukamoto, Shokichi ^a   Takeuchi, Masahiro ^a   Kawajiri, Chika ^a   Tanaka, Satomi ^a   Nagao, Yuhei ^a   Sugita, Yasumasa ^a   Yamazaki, Atsuko ^a   Kawaguchi, Takeharu ^a   Muto, Tomoya ^a   Sakai, Shio ^a   Takeda, Yusuke ^a   Ohwada, Chikako ^a   Sakaida, Emiko ^a   Shimizu, Naomi ^a   Yokote, Koutaro ^b   Iseki, Tohru ^a   Nakaseko, Chiaki ^a  

^a CHIBA UNIVERSITY HOSPITAL   (Japan)

^b CHIBA UNIVERSITY   (Japan)

Author keywords

Acute lymphoblastic leukemia (ALL); Adult; L asparaginase; Posterior reversible encephalopathy syndrome (PRES); Vincristine

Indexed keywords

ANTICONVULSIVE AGENT; ANTIHYPERTENSIVE AGENT; ASPARAGINASE; CORTICOSTEROID; CYCLOPHOSPHAMIDE; DAUNORUBICIN; PREDNISONE; VINCRISTINE; ANTINEOPLASTIC AGENT;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADULT; ALLOGENIC BONE MARROW TRANSPLANTATION; ARTICLE; CANCER CHEMOTHERAPY; CANCER REGRESSION; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; CONVULSION; FEMALE; HUMAN; HYPERTENSION; ILEUS; MUSCLE WEAKNESS; NUCLEAR MAGNETIC RESONANCE IMAGING; POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME; VISUAL ACUITY; CHEMICALLY INDUCED DISORDER; PATHOLOGY; RADIOGRAPHY; REMISSION;

ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; ASPARAGINASE; CYCLOPHOSPHAMIDE; DAUNORUBICIN; FEMALE; HUMANS; POSTERIOR LEUKOENCEPHALOPATHY SYNDROME; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; PREDNISONE; REMISSION INDUCTION; VINCRISTINE;

EID: 84862679387     PISSN: 09255710     EISSN: 18653774     Source Type: Journal    
DOI: 10.1007/s12185-011-0982-9     Document Type: Article

References (23)

1. Hinchey J, Chaves C, Appignani B, Breen J, Pao L, Wang A, et al. A reversible posterior leukoencephalopathy syndrome. N Engl J Med. 1996;334:494-500. (Pubitemid 26067737)
2. Casey SO, Sampaio RC, Michel E, Truwit CL. Posterior reversible encephalopathy syndrome: utility of fluid-attenuated inversion recovery MR imaging in the detection of cortical and subcortical lesions. AJNR Am J Neuroradiol. 2000;21:1199-206. (Pubitemid 30655653)
3. de Laat P, Te Winkel ML, Devos AS, Catsman-Berrevoets CE, Pieters R, van den Heuvel-Eibrink MM. Posterior reversible encephalopathy syndrome in childhood cancer. Ann Oncol. 2011;22:472-8.
4. Miyazawa Y, Irisawa H, Matsushima T, Mitsui T, Uchiumi H, Saitohi T, et al. Reversible posterior leukoencephalopathy syndrome probably caused by L-asparaginase. Rinsho Ketsueki. 2006;47:531-5.
5. Reutenauer S, Albucher JF, Pariente J, Dumas H, Milioto O, Attal M, et al. Posterior reversible encephalopathy syndrome: two cases in young adults with acute lymphoblastic leukemia. Leuk Res. 2009;33:e1-3.
6. Feske SK. Posterior reversible encephalopathy syndrome: a review. Semin Neurol. 2011;31:202-15.
7. Vavilala MS, Kincaid MS, Muangman SL, Suz P, Rozet I, Lam AM. Gender differences in cerebral blood flow velocity and autoregulation between the anterior and posterior circulations in healthy children. Pediatr Res. 2005;58:574-8. (Pubitemid 41254527)
8. Panis B, Vlaar AM, van Well GT, Granzen B, Weber JW, Postma AA, et al. Posterior reversible encephalopathy syndrome in paediatric leukaemia. Eur J Paediatr Neurol. 2010;14:539-45.
9. Titos-Arcos JC, Leon-Villar J, Amigo-Lozano ML, Muina-Juarez B. Posterior reversible leukoencephalopathy syndrome induced by L-asparaginase in a teenage female diagnosed with acute lymphoblastic leukemia. Rev Neurol. 2011;52:58-60.
10. Rathi B, Azad RK, Vasudha N, Hissaria P, Sawlani V, Gupta RK. L-asparaginase-induced reversible posterior leukoencephalopathy syndrome in a child with acute lymphoblastic leukemia. Pediatr Neurosurg. 2002;37:203-5. (Pubitemid 35316916)
11. Hourani R, Abboud M, Hourani M, Khalifeh H, Muwakkit S. L-asparaginase-induced posterior reversible encephalopathy syndrome during acute lymphoblastic leukemia treatment in children. Neuropediatrics. 2008;39:46-50. (Pubitemid 351828318)
12. Parasole R, Petruzziello F, Menna G, Mangione A, Cianciulli E, Buffardi S, et al. Central nervous system complications during treatment of acute lymphoblastic leukemia in a single pediatric institution. Leuk Lymphoma. 2010;51:1063-71.
13. Schneider P, Van Dreden P, Rousseau A, Kassim Y, Legrand E, Vannier JP, et al. Increased levels of tissue factor activity and procoagulant phospholipids during treatment of children with acute lymphoblastic leukaemia. Br J Haematol. 2010;148:582-92.
14. Lucchini G, Grioni D, Colombini A, Contri M, De Grandi C, Rovelli A, et al. Encephalopathy syndrome in children with hemato- oncological disorders is not always posterior and reversible. Pediatr Blood Cancer. 2008;51:629-33.
15. Norman JK, Parke JT, Wilson DA, McNall-Knapp RY. Reversible posterior leukoencephalopathy syndrome in children undergoing induction therapy for acute lymphoblastic leukemia. Pediatr Blood Cancer. 2007;49:198-203. (Pubitemid 47041112)
16. Gupta A, Swaroop C, Rastogi R, Garg R, Bakhshi S. Simultaneous occurrence of posterior reversible leukoencephalopathy syndromein two cases of childhood acute lymphoblastic leukemia induction chemotherapy. Pediatr Hematol Oncol. 2008;25:351-8. (Pubitemid 351874089)
17. Pui CH, Evans WE. Treatment of acute lymphoblastic leukemia. N Engl J Med. 2006;354:166-78. (Pubitemid 43076714)
18. Hoshino K, Asou N, Suzushima H, Osato M, Yamasaki H, Okubo T, et al. TEL/AML1 fusion gene resulting from a cryptic t(12;21) is uncommon in adult patients with B-cell lineage ALL and CML lymphoblastic transformation. Int J Hematol. 1997;66:213-8. (Pubitemid 27360185)
19. Boissel N, Auclerc MF, Lheritier V, Perel Y, Thomas X, Leblanc T, et al. Should adolescents with acute lymphoblastic leukemia be treated as old children or young adults? Comparison of the French FRALLE-93 and LALA-94 trials. J Clin Oncol. 2003;21:774-80. (Pubitemid 46606434)
20. de Bont JM, Holt B, Dekker AW, den Berg A, Sonneveld P, Pieters R. Significant difference in outcome for adolescents with acute lymphoblastic leukemia treated on pediatric vs adult protocols in the Netherlands. Leukemia. 2004;18:2032-5. (Pubitemid 40028431)
21. Ramanujachar R, Richards S, Hann I, Goldstone A, Mitchell C, Vora A, et al. Adolescents with acute lymphoblastic leukaemia: outcome on UK national paediatric (ALL97) and adult (UKALLXII/E2993) trials. Pediatr Blood Cancer. 2007;48:254-61. (Pubitemid 46238513)
22. Usvasalo A, Raty R, Knuutila S, Vettenranta K, Harila-Saari A, Jantunen E, et al. Acute lymphoblastic leukemia in adolescents and young adults in Finland. Haematologica. 2008;93:1161-8.
23. Huguet F, Leguay T, Raffoux E, Thomas X, Beldjord K, Delabesse E, et al. Pediatric-inspired therapy in adults with Philadelphia chromosome-negative acute lymphoblastic leukemia: the GRAALL-2003 study. J Clin Oncol. 2009;27:911-8.